🔴 Vera Therapeutics is trading 4.2% down today amid a broad biotech selloff

Vera Therapeutics is trading at $31.65 (down 4.2%) amid a broad selloff in the biotech sector and mixed overall market conditions.

• The move appears driven by sector-wide pressure and risk-off sentiment rather than any new company-specific catalysts or FDA updates.
• There is no fresh news following the company's prior announcement regarding the IgA nephropathy BLA priority review and its July 7, 2026, PDUFA date.